DON’T MISS
IamExpat FairIamExpat Job BoardIamExpat Webinars
Newsletters
EXPAT INFO
CAREER
HOUSING
EDUCATION
LIFESTYLE
EXPAT SERVICES
NEWS & ARTICLES
Home
Expat Info
German news & articles
Germany to start using new drug amid COVID-19 vaccine shortage
Never miss a thing!Sign up for our weekly newsletters with important news stories, expat events and special offers.
Keep me updated with exclusive offers from partner companies
By signing up, you agree that we may process your information in accordance with our privacy policy

Germany to start using new drug amid COVID-19 vaccine shortage

Never miss a thing!Sign up for our weekly newsletters with important news stories, expat events and special offers.
Keep me updated with exclusive offers from partner companies
By signing up, you agree that we may process your information in accordance with our privacy policy
or
follow us for regular updates:



Related Stories

Germany: How businesses continue to operate during the corona crisisGermany: How businesses continue to operate during the corona crisis
Who was Saint Corona and why are people asking for her help?Who was Saint Corona and why are people asking for her help?
Germany flies in more coronavirus patients from France and ItalyGermany flies in more coronavirus patients from France and Italy
Coronavirus could cost Germany 730 billion eurosCoronavirus could cost Germany 730 billion euros
Germany looks to pass proposals for autumn COVID measuresGermany looks to pass proposals for autumn COVID measures
Life expectancy falls significantly in several German statesLife expectancy falls significantly in several German states
Thousands flood the streets in Germany to protest coronavirus restrictionsThousands flood the streets in Germany to protest coronavirus restrictions
Germany adds five countries to high coronavirus risk listGermany adds five countries to high coronavirus risk list
For expats of all colours, shapes and sizes

Explore
Expat infoCareerHousingEducationLifestyleExpat servicesNews & articles
About us
IamExpat MediaAdvertisePost a jobContact usImpressumSitemapRSS feeds
More IamExpat
IamExpat Job BoardIamExpat HousingIamExpat FairWebinarsNewsletters
Privacy
Terms of usePrivacy policyCookiesAvoiding scams

Never miss a thing!Sign up for expat events, news & offers, delivered once a week.
Keep me updated with exclusive offers from partner companies
By signing up, you agree that we may process your information in accordance with our privacy policy


© 2025 IamExpat Media B.V.
© 2025 IamExpat Media B.V.
Jan 26, 2021
William Nehra
William studied a masters in Classics at the University of Amsterdam. He is a big fan of Ancient History and football, particularly his beloved Watford FC. Read more

The German federal government has purchased a new antibody-based drug to treat coronavirus patients, as shortages hamper the country’s vaccination programme.

Germany to use new antibody-based drug

German Health Minister Jens Spahn has told reporters that the government has bought 200.000 doses of a new antibody-based drug for 487 million euros, to help combat coronavirus in Germany. Spahn said that the new treatment acts “like a passive vaccination.” He added, “Administering these antibodies in the early stages can help high-risk patients avoid a more serious progression.”

The so-called “monoclonal antibodies” will be rolled out across Germany from next week, making the federal republic the first country in Europe to implement their use. They will be initially used in university hospitals.

The new treatment is the same that was given to ex-President Donald Trump when he was briefly hospitalised with the virus. Trump was administered with the REGEN-COV2 antibody cocktail from US biotechnology company, Regeneron.

The blame game

After getting off to a relatively speedy start, Germany’s vaccine programme has been hampered by delivery issues in recent weeks. Despite his earlier warnings that supply of the vaccine would be limited initially, Spahn has come under growing criticism for the situation. In response, Spahn warned against pointing fingers at individuals during the current crisis.

"We should be careful that 2021 does not become the year of blame," Spahn told reporters. "Talking about mistakes and failures is important. But without it becoming relentless and only being about shifting blame onto others."

Spahn acknowledged that Germany should have enacted tougher measures from as early as October when infection rates were lower. "It takes decisive government action, but it also takes responsible behaviour from everyone. We are all in the same boat," he said.

Restrictions remain for the vaccination

Spahn also said that vaccinated people would continue to be subject to Germany’s coronavirus restrictions until vaccines are available for all citizens. “We've stood in solidarity through this pandemic for a year,” he said. “Now we might as well all play by the rules for the remaining months until everyone can be vaccinated."

Epidemiologists have said that the debate over whether Germany should lift its restrictions is too early. "If the current lockdown is relaxed too soon, we risk a third wave, which will hit us harder because the new virus variant is much more contagious," said Eva Green, the president of the German Society for Epidemiology.

By William Nehra